Table 4.
Individual Characteristics and Mobilization Parameters in Patients Remobilized with G-CSF+Plerixafor
| Patient no. | Age (years) | Weight (kg) | Sex | Splenectomy | Initial mobilization | Initial mobilization max WBCs (×103/μl) | Remobilization max WBCs (×103/μl) | Remobilization mean G-CSF dose (mcg/kg/d) | Initial mobilization max CD34+(cells/μl) | Remobilization max CD34+(cells/μl) | Initial mobilization mean CD34+ cells/apheresis (×106/kg) | Remobilization mean CD34+ cells/apheresis (×106/kg) | Remobilization aphereses no. to reach target cell dose |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P04 | 38 | 77 | F | Y | G-CSF | 83.0 | 88.0 | 2.2 | 10 | 120 | 0.81 | 6.5 | 1 |
| P11 | 38 | 78 | M | Y | Plerixafor | 32.2 | 60.2 | 5.5 | 40 | 102 | 2.25 | 6.8 | 1 |
| P13 | 25 | 67 | F | N | Plerixafor | 27.0 | 59.5 | 10 | 17 | 108 | 1.25 | 12.7 | 1 |
| P17 | 26 | 62 | M | Y | Plerixafor | 22.8 | 98.3 | 6 | 15 | 132 | 0.63 | 9.4 | 1 |